SCHEMBL13184656

SCHEMBL13184656

CN(C)c1ccc(/C=C/C=C2\C(=O)NC(=O)N(c3ccc(Cl)cc3)C2=O)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.79
MEN1 O00255 10/20 0.79
KMT2A Q03164 10/20 0.79
ALDH1A1 P00352 6/20 0.79
NPSR1 Q6W5P4 6/20 0.79
L3MBTL1 Q9Y468 6/20 0.79
PKM P14618 5/20 0.79
MAPK1 P28482 4/20 0.79
PSMD14 O00487 2/20 0.79
THRB P10828 2/20 0.79
MMP2 P08253 1/20 0.79
PPARG P37231 1/20 0.79
NCOA2 Q15596 1/20 0.79
POLB P06746 4/20 0.59
LMNA P02545 3/20 0.59
KDM4E B2RXH2 2/20 0.59
NTSR1 P30989 2/20 0.59
METAP1 P53582 2/20 0.58
APP P05067 6/20 0.54
SNCA P37840 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13184632 0.90 MAPT (0.81) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL13184661 0.89 MAPT (0.79) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL29350119 0.88 MAPT (1.00) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL13184630 0.88 MAPT (1.00) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL12218050 0.84 MEN1 (0.82) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL13184631 0.81 MAPT (0.78) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL14713028 0.78 MAPT (0.67) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL14712877 0.76 MAPT (0.64) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL13164874 0.75 MAPT (0.63) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL13164871 0.75 MEN1 (1.00) MAPTMEN1KMT2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227853-A1 INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES TRUSTEES OF BOSTON COLLEGE (US) 2010-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227853-A1 INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES PDE7A, PDE4A, PDE4C MAPT 3911/4885MEN1 1933/4885KMT2A 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.